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Keloids and hypertrophic scars are fibroproliferative disorders of the skin. Research 
over the last decade has markedly improved our understanding of the pathogenesis of 
these scars, in particular, the fact that both disorders are caused by prolonged inflam-
mation that prevents the orderly healing of injured or irritated skin. This protracted 
inflammatory response is due to genetic, systemic, and local risk factors. Genetic factors 
include single nucleotide polymorphisms, while systemic factors include hypertension, 
pregnancy-related and other hormones, and aberrant cytokine levels. An important 
local factor is the mechanical force (tension) on the scar. These observations have 
greatly aided the development of therapies for these once-intractable scars. As a result, 
these scars are now regarded as being completely treatable. At present, we believe that 
the following combination of three therapies most reliably achieves a complete cure: 
surgery followed by radiation and the prolonged daily use of corticosteroid tape/plaster.
Keywords: keloid, hypertrophic scar, scar, scar contracture, fibroproliferative 
disorder, fibrosis, surgery, radiotherapy, corticosteroid, tape, plaster
1. Introduction
While keloids and hypertrophic scars have some tumor-like properties, they 
are actually inflammatory conditions that drive the excessive proliferation of 
dermal fibroblasts and the aberrant accumulation of dermal matrix [1]. These 
fibroproliferative disorders of the skin are caused by abnormal healing of injured 
or irritated skin. Common causes of injury and irritation are trauma, burn, surgery, 
vaccination, skin piercing, acne, and herpes zoster. The risk of developing keloids 
and hypertrophic scars is particularly high if the wound is deep enough to dam-
age the reticular layer of the dermis and if various genetic, systemic, and/or local 
risk factors that prolong the inflammatory stage of wound healing are present. 
The protracted inflammation accelerates angiogenesis and induces the excessive 
accumulation of collagen. As a result, red and elevated scars that have an unappeal-
ing appearance arise. These scars also associate with intermittent pain, persistent 
itching, and a sensation of contraction. Moreover, if the wounds are located on 
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the joints or mobile regions, including the neck, the resulting scars can develop 
into scar contractures. Thus, the primary end-points of treatments for keloids and 
hypertrophic scars should be functional improvement and relief from pain and itch. 
Another important goal is the esthetic improvement.
2. Causes of keloids and hypertrophic scars
A number of genetic, systemic, and local factors that influence the character-
istics and quantity of keloids and hypertrophic scars have been identified [2]. The 
genetic causes of pathological scar development include single nucleotide poly-
morphisms [3, 4]. Moreover, our study showed that one of these polymorphisms 
associates significantly with clinically severe keloids [4]. It has been suggested that 
keloids are more influenced by genetic background than hypertrophic scars. This 
notion remains to be tested. To test it, it will be necessary to have a critical bio-
marker that reliably distinguishes keloids from hypertrophic scars. One possibility 
is keloidal collagen: it seems that this histological feature is only present in lesions 
that bear other classical hallmarks of keloids, including growth over the edges of the 
original wound. However, identification of other, nonpathology, biomarkers would 
be highly useful for addressing questions about the differences between keloids and 
hypertrophic scars in terms of their etiology, growth characteristics, and treatment 
responses.
In terms of systemic factors, adolescence and pregnancy appear to associate 
with a higher risk of developing pathological scars [5, 6]. Our recent study also 
showed that hypertension associates with the development of severe keloids [7, 8]. 
I believe that while these factors are not primary causes of keloid and hypertrophic 
scars, they do worsen the inflammation in the scar tissue, thereby accelerating and 
increasing angiogenesis and matrix production.
Of the many factors that contribute to pathological scar development is local 
mechanical forces, I believe that they play a particularly important role [9–11]. 
Keloids commonly adopt distinct site-specific shapes, namely, the typical butterfly, 
crab’s claw, and dumbbell shapes on the shoulder, anterior chest, and upper arm, 
respectively. These shapes reflect the region-specific distribution of skin tension that 
then tugs repetitively or constantly on the wounds/scars. Moreover, keloids are rare 
on the upper eyelid. This reflects the fact that eyelid skin is always relaxed regardless 
of whether the eyes are open or closed. An exception may be earlobe keloids: the con-
tribution of mechanical factors to the development of these keloids may be minor. 
Instead, the most likely local cause of these keloids is the repeated attaching and 
detaching of the piercing, which repeatedly injures the skin and heightens the risk of 
infection. Both the skin tension and repeated injury/infection trigger inflammation 
and the downstream fibroproliferative events. In summary, while skin tension itself 
may not be a primary cause of keloids and hypertrophic scars, it is likely to be an 
important local risk factor that worsens and prolongs the inflammation that drives 
the formation and/or progression of these fibroproliferative scars.
3. Standard treatment of keloids and hypertrophic scars
These findings have markedly improved our understanding of the pathogenesis 
of keloids and hypertrophic scars, which in turn has promoted the development of 
highly effective treatments for these once-intractable scars. At present, I believe 
that the most reliable approach is a combination of three therapies, namely, surgery, 
followed by radiation, and prolonged daily use of steroid tape/plaster. The addition 
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of radiation and steroid tape/plaster to surgery reflects the point made above, 
namely, that keloids and hypertrophic scars are inflammatory disorders, and not 
tumors. Consequently, anti-inflammatory treatments are most effective for these 
lesions. Indeed, as will be described below, steroid tapes/plasters/injections on their 
own work well to reduce the volume of accumulated collagen in keloids and hyper-
trophic scars, thereby causing their mass to shrink. However, steroid treatments 
take a long time to achieve mass reduction. Consequently, with large lesions, they 
are best performed after surgery that rapidly removes the lesion mass. Radiation 
on its own also has mass-reducing effects because it appears to suppress angiogen-
esis, and therefore dampens the influx of inflammatory cells and factors into the 
scar. These anti-inflammatory properties of steroid and radiation mean that their 
application after mass-reducing surgery (which by itself provokes inflammatory 
responses) will prevent the recurrence of excised keloids and hypertrophic scars.
Below, we will describe each of the three modalities separately. Thereafter, 
we will describe the three modalities when used in our combination therapeutic 
protocol.
3.1 Surgery
Since surgical treatment itself induces inflammation, surgery alone associates 
with high rates of keloid and hypertrophic scar recurrence. Worse, the recurrent 
scars are often much bigger than the original lesions. Thus, unless the scar is a 
minor hypertrophic scar, the decision to surgically remove a pathological scar 
should be made very carefully and postoperative radiation therapy should always 
be performed. However, if keloids and hypertrophic scars have infected areas, such 
as inclusion cysts, these should be removed surgically. Another key indication for 
surgery is keloids and hypertrophic scars that result in scar contracture of the joints 
or mobile areas such as the neck. In this case, the contractures should be released 
by a combination of subcutaneous/fascial tensile reduction sutures, z-plasties, and 
regional/local flap transfer.
The main objective of surgery for keloids and hypertrophic scars is not only 
mass reduction, but it is also to reduce the mechanical tension on the scar or the 
wound that is left after surgical removal of the scar. This is due to the important role 
of mechanical tension in the development and progression of keloids and hypertro-
phic scars. This is reflected by the fact that the most effective surgical method for 
releasing scar contractures is to use a regional or local flap, especially skin-pedicled 
local flaps: these flaps are particularly useful because they expand naturally after 
surgery and are therefore not prone to postsurgical contractures [12]. In contrast, 
skin grafts do not expand, which means that skin grafting tends to generate second-
ary contractures that result in circular pathological scars around the grafted skin.
3.2 Radiation
Interestingly, keloids respond very well to primary radiation therapy (i.e., radiation 
monotherapy). This reflects the fact that radiotherapy has a strong anti-inflammatory 
effect. Primary radiation therapy is suitable for older patients or patients with severe 
(huge) keloids (Figure 1). Since the total radiation dose in these cases is relatively high 
(e.g., 5 Gy administered once a week for 5 weeks by superficial brachytherapy), it is 
necessary to apply the radiation carefully to prevent secondary radiation carcinogen-
esis. However, the risks of primary radiation therapy should be weighed against its 
tremendous benefits; in particular, the fact that it immediately alleviates the subjective 
symptoms of keloids such as pain and itching. Moreover, over the following year, it 
causes the color and thickness of the scars to progressively normalize.
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Radiation is also useful in the treatment of keloids and hypertrophic scars as a 
postsurgical modality [13–21]. As mentioned above, the main problem of surgery 
for pathological scars is recurrence. However, postsurgical radiation therapy can 
dramatically reduce these rates of recurrence. Use of the linear-quadratic model to 
calculate the biologically effective doses (BEDs) for various therapeutic radiation 
regimens after surgical excision of keloids showed that when the BED exceeds 30 Gy, 
the recurrence rate is less than 10%. Indeed, our review of the literature showed that 
to ensure maximum efficacy and safety, postoperative radiation for keloids in adults 
should involve the application of 10–20 Gy via daily fractions of 5 Gy.
Currently, we propose that the maximum dose of postoperative radiation 
therapy for surgically excised keloids is a BED of 30 Gy. A BED of 30 Gy can be 
obtained in several ways: a single fraction dose of 13 Gy, two fractions of 8 Gy, 
three fractions of 6 Gy, or four fractions of 5 Gy. In addition, recommended site-
dependent dose protocols for the treatment of keloids are as follows: 18 Gy in three 
fractions over 3 days for the anterior chest wall, shoulder-scapular region, and 
suprapubic region; 8 Gy in a fraction over a day for the ear lobe; and 15 Gy in two 
fractions over 2 days for other sites.
It should be noted that the calculated BED of 30 Gy assumes that the α/β ratio 
for keloids is 10 (the α/β ratio is a measure of the radiosensitivity of a specific 
tissue). However, when Flickinger [21] investigated the α/β ratio of keloids, they 
found that it was as low as 2, which suggests that high doses with limited numbers 
of fractions is the best strategy to achieve low recurrence rates. At present, there 
is no widely accepted radiation regimen for keloid treatment. Further research on 
regimens that effectively prevent recurrence without elevating the risk of secondary 
carcinogenesis is welcome.
3.3 Corticosteroid tapes/plasters
Corticosteroid injections rapidly reduce the volume of a scar [22]. However, 
the downsides of corticosteroid injections include pain (caused by the injection 
itself) and difficulties associated with contraindications such as pregnancy, glau-
coma, or Cushing’s disease. This problem can be overcome by using steroid tapes/
plasters. Most pediatric and older patients can be treated by steroid tapes/plaster 
alone because they have much thinner skin, which means that the steroids are easily 
absorbed (Figure 2). Corticosteroid tape/plasters on their own or in combination 
Figure 1. 
A patient with severe abdominal keloids was effectively treated by radiation monotherapy. (a) View before 
treatment. (b) 4 months post-treatment. (c) 9 months post-treatment. (d) 14 months post-treatment.  
(e) 18 months post-treatment. A 68-year-old female was treated with high-dose-rate superficial brachytherapy. 
A total of 25 Gy was administered in five fractions over 5 days (i.e., 5 Gy was delivered once a week for 
5 weeks). After 4 months of treatment, both the subjective and objective symptoms had improved dramatically. 
The keloids became mature scars 18 months after the treatment.
5Keloids and Hypertrophic Scars Can Now Be Treated Completely by Multimodal Therapy…
DOI: http://dx.doi.org/10.5772/intechopen.84178
with other therapies such as corticosteroid injection are also suitable for adults with 
minor keloids. Notably, postoperative application of corticosteroid tape/plasters sig-
nificantly prevents the development of keloids and hypertrophic scars after surgery.
Steroid tape/plasters should be changed every day. Important tips regarding the 
treatment of keloids and hypertrophic scars with steroid tapes/plasters are as fol-
lows. First, the patient should continue to use the tapes/plasters until the elevated 
mass becomes flat and soft. Second, once the mass has become flat and soft, steroid 
tape/plaster use should be stopped, even if the scar is still red. This reflects the fact 
that if the patient continues to use the tape just because the scar is still red, capil-
larectasia will occur. This is because the steroid treatment thins the supporting 
structure of the blood vessels.
Steroid tape is available in the following three countries in slightly different 
preparations [22]. In the UK, the commercially available formulation comprises a 
fludroxycortide-impregnated tape (4 μg/cm2). In the USA, a preparation containing 
4 μg/cm2 flurandrenolide (a medium-strength steroid) is available. In Japan, two 
steroid tape formulations are available, namely, a 4 μg/cm2 fludroxycortide tape 
(medium-strength) and a 20 μg/cm2 deprodone propionate tape (higher potency 
steroid). In our experience, deprodone propionate tape is the most effective tape for 
the treatment and prevention of keloids.
4. Combination treatment for severe keloids and hypertrophic scars
If a patient has severe keloids with infected areas or scar contractures, surgery 
should be performed (Figure 3). If the keloids are too large to be removed in their 
entirety, the surgeon can resect the region of contracture or infection. The resulting 
defects can then be covered by a regional/local flap. Surgery should also be performed 
if the keloid growth causes significant deformity and the keloid does not respond to 
nonsurgical therapies. An example of severely deforming earlobe keloids is shown in 
Figure 4. Such keloids can be treated by the core excision method, where the fibrous 
reticular layer of the keloid (i.e., the core of the earlobe keloid) is extirpated and the 
epidermis and papillary layer of the dermis is preserved as a thin flap.
Figure 2. 
A child with a mild keloid was effectively treated with steroid tape alone. (a) View before treatment. (b) After 
16 months of treatment. (c) After 26 months of treatment. This 9-year-old boy had a mild right scapular keloid 
and was treated by fludroxycortide tape (Drenison® tape). The tape was placed on the keloid 24 h a day and 
was changed daily. The inflammation resolved completely. After 26 months of treatment, both the subjective 
and objective symptoms of the patient had improved dramatically (the case was cited from the article: Ogawa 
R, Akaishi S, Kuribayashi S, Miyashita T. Keloids and Hypertrophic Scars Can Now Be Cured Completely: 
Recent Progress in Our Understanding of the Pathogenesis of Keloids and Hypertrophic Scars and the Most 
Promising Current Therapeutic Strategy. J Nippon Med Sch. 2016;83(2):46–53).
Scars
6
While these surgical approaches on their own associate with a relatively high 
risk of recurrence, this risk can be significantly reduced by combining surgery with 
postoperative radiotherapy and prolonged corticosteroid tape/plaster application. 
Thus, after the operation, both the donor and recipient sites of the flap should be 
irradiated to prevent the new formation of keloids. Notably, when partial resection 
or core extirpation is followed by postoperative radiotherapy, any remaining keloids 
around the flap (which do not undergo radiotherapy) also improve (Figure 3). This 
Figure 3. 
A patient with an upper limb keloid was effectively treated by surgery and postoperative radiotherapy.  
(a) Preoperative view. (b) Removal of the hand and wrist keloids and harvest of the flap. (c) Flap rotation. 
(d) The recipient site immediately after surgery. (e–i) 5 years after the operation. This 63-year-old female 
had hypertension together with severe keloids of an unknown origin (folliculitis was suspected) that covered 
her right elbow, wrist joint, and thumb and made it difficult for her to use her right hand. The contractures 
were released by surgery with a distally based radial forearm flap followed by adjuvant 4-MeV electron beam 
irradiation therapy (15 Gy/three fractions for 3 days) (the case was cited from the article: Ogawa R, Arima 
J, Ono S, Hyakusoku H. CASE REPORT Total Management of a Severe Case of Systemic Keloids Associated 
With High Blood Pressure (Hypertension): Clinical Symptoms of Keloids May Be Aggravated by Hypertension. 
Eplasty. 2013 Jun 3;13:e25).
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reflects the fact that the flap releases tension, which in turn decreases the inflam-
mation in the remnant keloids. The high risk of recurrence in these severe cases 
can be further reduced by the routine application of corticosteroid tape/plasters 
on the operated area that are changed daily. In general, we recommend patients to 
use tape/plasters for at least 6 months after the surgery and radiotherapy, or until 
the scar becomes soft. Long-term follow-up is necessary because if the scars start 
to stiffen again, corticosteroid tape/plasters should be re-applied. In general, it will 
Figure 4. 
A patient with bilateral ear keloids was effectively treated by surgery and postoperative radiotherapy.  
(a, b) Preoperative view of the left ear. (c) Design of the incision on the left ear. (d) Intraoperative view of the left 
ear. (e, f) The left ear immediately after surgery. (g) Preoperative view of the right ear. (h) Design of the incision 
on the right ear. (i) Intraoperative view (the right ear). (j, k) The right ear immediately after surgery. (l, m) The 
right ear 14 months after surgery. (n, o) The left ear 14 months after surgery. A 37-year-old Japanese woman 
with multiple keloids was diagnosed with multicentric type Castleman’s disease. She was treated with systemic 
administration of steroid for Castleman’s disease but the treatment did not improve her keloids. We removed both 
auricular keloids by using the core excision method. On postoperative days 1, 2, and 3, the patient received a total 
radiation dose of 15 Gy in three fractions over 3 days. The radiation was delivered by a 4 MeV electron beam. 
Histopathological examination of the resected tissues showed the absence of abnormal lymphocytes or plasma cell 
infiltration. Consequently, the auricular lesions were diagnosed definitively as keloids (the case was cited from the 
article: Quong WL, Kozai Y, Ogawa R. A Case of Keloids Complicated by Castleman’s Disease: Interleukin-6 as a 




Algorithm for selecting keloid and hypertrophic scar treatment modalities. Particular care should be taken 
when selecting the treatment for growing children and pregnant women with keloids and hypertrophic scars. In 
our facility, pediatric patients (<20 years of age) and pregnant women are not treated with radiation. Invasive 
surgery in pregnant women is also avoided. In these cases, the primary treatment choice should be steroid tape/
plaster together with stabilization/compression therapy that reduces the tension on the scar.
9© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
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take at least 2 years before combination therapy-treated keloids and hypertrophic 
scars mature. It is important to make clear to the patient before this therapy starts 
that the protocol has a long duration. Nevertheless, close monitoring and assidu-
ous re-application of steroid tape/plasters have an excellent chance of converting 
postoperative keloid sites into mature scars.
It should be noted that our combination therapy is not suitable for growing 
children and pregnant women. In our facility, we do not treat pediatric patients 
(<20 years of age) or pregnant women with radiation. Moreover, invasive treat-
ments such as surgery are not performed during pregnancy. The primary choice of 
treatment for children and pregnant women with keloids and hypertrophic scars 
should be steroid tape/plaster on its own (Figure 5).
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